Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nanochon logo — Nanochon is developing highly effective, minimally invasive...

Nanochon

Nanochon is developing highly effective, minimally invasive and low cost solutions for cartilage loss and damage.

Founded 2016 United States Washington, United States 12 employees Non Equity Assistance Total: $10.22M Biotechnology, Medical Devices +1

General Information

Company Name Nanochon
Founded Year 2016
Location United States Washington, United States +1
Employees 12
Industries Biotechnology, Medical Devices, 3D Printing
Funding Stage Non Equity Assistance
Social

Get notified when Nanochon moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Nanochon

Nanochon is a biotechnology startup based in the United States, founded in 2016. The company is focused on developing innovative solutions for cartilage loss and damage, aiming to revolutionize the treatment of joint diseases. Its slogan, "Nanochon is developing highly effective, minimally invasive and low cost solutions for cartilage loss and damage," encapsulates its mission. Currently, the standard treatment for joint disease is total joint replacement, which is invasive and not permanent, limiting its use to patients aged 55 or older. Nanochon addresses this gap by developing an implant that not only replaces lost and damaged cartilage but also stimulates new tissue growth. Utilizing 3-D printing and a novel material, the Nanochon implant serves as both an orthopedic load-bearing implant and a tissue growth scaffold, offering the potential for faster and more successful recoveries for patients. Cultivate(MD) made a Venture Round investment in Nanochon on 27 November 2023. This investment signifies external validation of Nanochon's innovative approach and its potential to significantly impact the orthopedic and biotechnology industries. Nanochon's efforts not only aim to improve patient outcomes but also to reduce costs for health providers, payers, and patients, setting a new clinical standard for cartilage restoration.

Taxonomy: Nanochon, implantable medical device, orthopedics, cartilage restoration, tissue engineering, joint repair, 3D printing, nanomaterial, minimally invasive, treatment options, sports medicine, cartilage damage, scaffold, joint disease

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance •••••• 1
Investor
29 May 2024
Seed Round •••••• 4
Investor Investor Investor
•••• •••• 		06 May 2024
Venture Round •••••• 1
Investor
27 Nov 2023
Venture Round •••••• - 28 Aug 2023
Seed Round •••••• 3
Investor Investor Investor
16 Sep 2021

View All 8 Funding Rounds

Nanochon Alternatives & Competitors

Nanochon vs
CartiHeal
CartiHeal Israel

www.cartiheal.com

Corporate Round
19 employees
Health Care, Manufacturing
Nanochon vs
ORTEQ Sports Medicine
ORTEQ Sports Medicine United Kingdom

We aim to reduce patient suffering from meniscus and articular cartilage injury or degeneration by c...

Series Unknown
9 employees
Biotechnology, Health Care
Nanochon vs
Regenosine
Regenosine United States

Harnessing the healing potential of adenosine for tissue regeneration

Grant
2 employees
Biotechnology, Health Care

FAQ About Nanochon

Nanochon is developing highly effective, minimally invasive and low cost solutions for cartilage loss and damage.
Nanochon was founded in 2016.
Nanochon is headquartered in Washington, United States.
Nanochon operates in the following industries: Biotechnology, Medical Devices, 3D Printing.
Nanochon has approximately 12 employees.
Nanochon has completed 8 funding rounds, raising a total of $10.22M. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to Nanochon include CartiHeal, ORTEQ Sports Medicine, Regenosine, Zahn Chiropractic Clinic, ABS Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nanochon and CartiHeal are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Nanochon and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy